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A significant number of women in low and middle income countries (L-MICs) who need any
family planning, experience a lack in access to modern effective methods. This study was
conducted to review potential cost effectiveness of scaling up family planning interventions
in these regions from the published literatures and assess their implication for policy and
future research.
Study design
A systematic review was performed in several electronic databases i.e Medline (Pubmed),
Embase, Popline, The National Bureau of Economic Research (NBER), EBSCOHost, and
The Cochrane Library. Articles reporting full economic evaluations of strategies to improve
family planning interventions in one or more L-MICs, published between 1995 until 2015
were eligible for inclusion. Data was synthesized and analyzed using a narrative approach
and the reporting quality of the included studies was assessed using the Consolidated
Health Economic Evaluation Reporting Standards (CHEERS) statement.
Results
From 920 references screened, 9 studies were eligible for inclusion. Six references
assessed cost effectiveness of improving family planning interventions in one or more L-
MICs, while the rest assessed costs and consequences of integrating family planning and
HIV services, concerning sub-Saharan Africa. Assembled evidence suggested that improv-
ing family planning interventions is cost effective in a variety of L-MICs as measured against
accepted international cost effectiveness benchmarks. In areas with high HIV prevalence,
integrating family planning and HIV services can be efficient and cost effective; however the
evidence is only supported by a very limited number of studies. The major drivers of cost
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effectiveness were cost of increasing coverage, effectiveness of the interventions and coun-
try-specific factors.
Conclusion
Improving family planning interventions in low and middle income countries appears to be
cost-effective. Additional economic evaluation studies with improved reporting quality are
necessary to generate further evidence on costs, cost-effectiveness, and affordability, and
to support increased funding and investments in family planning programs.
Introduction
Family planning allows people to attain their desired number of children, which is achieved
through the use of effective contraceptive methods [1]. However, despite the decrease of
unmet need for family planning globally for the last two decades [2], a significant number of
women in low and middle income countries (L-MICs) who need any family planning methods
to delay or cease fertility, still experience a lack in access to modern effective methods [1,2].
Ensuring access to family planning services is one of the crucial strategies to ensure the health
and well-being of women, as a woman’s abilities to limit, plan and manage her pregnancies
have a direct impact on her health outcomes as well as on the outcomes of pregnancies [1].
Unmet need for family planning is associated with a considerable amount of disability-
adjusted life years and also one third of maternity-related disease burden [3–5]. It is estimated
that by improving family planning interventions, the risk of maternal death can be decreased
as much as 40% [3,6]. This risk can be reduced by preventing high-risk pregnancies in for
instance, women of high parities, as well as by preventing pregnancies in those who would oth-
erwise be exposed to unsafe abortion [6]. Additionally, unmet need is especially high among
adolescents, migrants, urban slum dwellers, refugees, women in the postpartum period and
women with HIV [7,8].
Family planning is one of the important drivers of progress towards target of Millennium
Development Goal (MDG) no 5, i.e. to improve maternal health [9,10]. Reducing the unmet
need for family planning is included in the continuum of care in reproductive, maternal, new-
born and child health (RMNCH), which is one of the pillars in MDG 5. Despite the recom-
mendation, access to any of these interventions is still insufficient in many L-MICs [11].
In order to prioritize among many competing global health needs in these resource-con-
strained regions, evaluation to identify not only effective but also cost-effective strategies needs
to be addressed. As a matter of fact, economic evaluation studies to assess both costs and effec-
tiveness of global health interventions are increasingly considered in the decision making pro-
cess in L-MICs [12]. Some studies have already been published aiming to summarize the
evidence on the effectiveness as well as cost effectiveness of approaches to improve maternal
and infant health care [13–15]. However, the synthesis of evidence on cost effective strategies
in early interventions, such as family planning, remains limited.
The aim of this study is to conduct a systematic review of published economic evaluation
studies, providing a synthesis of evidence on costs, consequences and cost-effectiveness of strat-
egies to improve family planning interventions in L-MICs and assess their implication for policy
and future research. Increased investments in family planning are needed especially in L-MICs
where unmet need is still high [2,16,17]. Additionally, the term ‘unmet need for family plan-
ning’ in this study refers to the proportion of women who do not want to become pregnant, but
Economic Evaluation of Family Planning
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are not using any contraceptive method [8]. Information on the economic value to assess the




The literature search followed the PRISMA guidelines (Preferred Reporting Items for System-
atic Reviews and Meta-Analysis) [19]. Medline (Pubmed), Embase, Popline, The National
Bureau of Economic Research (NBER), EBSCOHost, and The Cochrane Library databases
were reviewed. In addition, we also searched the homepages of a number of major interna-
tional organizations which covered research in family planning such as the World Health
Organization (WHO), the Guttmacher Institute, the World Bank, United Nations Population
Fund (UNFPA), USAID and the Population Council. The combination of terms “AND” and
“OR” as well as (MeSH) and text words were used to narrow the search. The key search strate-
gies applied in the databases included several terms related to the following three concepts: 1)
family planning, 2) costs or economic evaluation, and 3) L-MICs in accordance with The
World Bank (including low income, lower-middle income, and upper-middle income econo-
mies) [20]. S1 Appendix summarizes the search terms used in the electronic databases.
Study selection and inclusion criteria
The initial search results from electronic databases were exported to a reference manager pack-
age, i.e. Refworks, and checked for duplicates. Afterwards, preliminary screening based on title
and abstract, followed by a full-text review of the selected articles was performed by two
reviewers (NZ and ADIvA) using the following inclusion criteria:
• Type of studies–Economic evaluation assessing strategies to improve family planning inter-
ventions in L-MICs settings (based on The World Bank classification of income groups)
[20]. The studies can be in the form of cost-analysis (CA), cost effectiveness analysis (CEA),
cost-utility analysis (CUA), and cost-benefit analysis (CBA) [21].
• Interventions–All strategies associated with improved family planning interventions (by
means of the holistic approach of the program), including interventions to specific popula-
tion groups with high unmet need such as adolescents, refugees, women in the postpartum
period and women with HIV.
• Participants–Women in the reproductive age
• Time limits–The article search was limited to the period between January 1995 until April
2015.
The articles that were selected from the international organization websites were screened
in the same manner. Any disagreements and differences on the study selection were discussed.
Economic evaluation studies assessing specific methods of contraceptives, studies exceeding
the pre-specified time limits, and conference proceedings were excluded.
Data extraction
Study characteristics, methodology, study design (including country/setting, perspective,
model type, time horizon and discount rates), parameters and results were extracted from full
text articles. When several interventions were assessed, only outcomes measured in regard to
family planning were extracted. Thresholds based on per capita gross domestic product (GDP)
Economic Evaluation of Family Planning
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were used for considering cost-effectiveness. When any necessary information was not avail-
able in the main text, supplementary data were observed. The funding of a study was directly
obtained from acknowledgments or other sources of funding. Extracted information was sum-
marized in Tables 1 and 2.
Main findings and data synthesis
The incremental cost effectiveness ratios (ICERs) and other outcome measures were adjusted
to 2014 USD by using inflation rates from the World Bank annual Consumer Price Index and
purchasing power parities (PPPs) for comparability. In data synthesis, a narrative approach
was used to analyze the findings due to diversity in interventions, comparators, methods and
study populations. The outcome measures and results from included studies were presented in
Table 2.
Quality of reporting
The quality of reporting of all included studies was assessed using the Consolidated Health
Economic Evaluation Reporting Standards (CHEERS) statement [22]. With the intention of
obtaining overall reporting quality assessments, studies were assigned 1 point per item if the
requirement from the checklist was fulfilled, 0.5 each when partially fulfilled and 0 point when
no or insufficient information was reported. Even though the CHEERS checklist is not
designed as scoring instrument, the application of a scoring method for CHEERS checklist has
been used and published elsewhere [15,23]. Twenty-four checklist items were divided into six
main categories (title and abstract, introduction, methods, results, discussion, and other).
These items were subsequently calculated as a percentage score with the underlying assump-
tion that all criteria were weighted equally and criteria which were not applicable were
excluded from the estimation. Studies with a score higher than 75% were categorized as good,
studies in the range 50–74% were categorized moderate and studies with scores lower than
50% were categorized as low. Even though in this way studies will be assigned a quality of
reporting score, this score is not a measure for the quality of the study. The mere fact that
some items were not reported on does not imply that study quality is low. Therefore, applying
the CHEERS checklist was mainly performed to provide additional information and not to
generate a weighting factor for study importance.
Results
Fig 1 shows the flow diagram for the identification of studies. The initial database search iden-
tified 920 published studies, of which 53 were excluded as duplicates. The additional search on
the homepages of international organizations discovered an extra 12 articles which appeared
relevant to the topic. The 879 studies thus identified were screened by title and abstract. Based
on this screening 865 studies were excluded, mainly because they analyzed a different topic,
for instance issues in pregnancy and abortion, concerned non-economic evaluation studies,
were not done in L-MICs, or published before the year 1995. The full texts of 14 studies were
retrieved for further screening and 6 of these were excluded. One extra relevant study [24] was
identified from the included reference during the full text screening, resulting in final inclu-
sion of 9 studies [24–32].
Overview of included studies
The characteristics of included studies are presented in Table 1. From the included studies, six
articles assessed the cost effectiveness of improving family planning interventions in Mexico
Economic Evaluation of Family Planning
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[25], India [26], Afghanistan [27], Nigeria [28], Uganda [29] and Pacific islands [30], of which
four were evaluating family planning as one of several interventions to reduce maternal
Table 1. Characteristics of the included studies.
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mortality [25–28]. The remaining three studies assessed strategies to reduce the unmet meet of
family planning for HIV-infected women by means of providing integrated family planning
and HIV services in multiple countries in Africa [24,31,32].
There were six single-country studies and three multi-country studies. Almost all country-
specific studies focused on improving family planning interventions in the general population,
while most multi-country studies were in African countries and examined the topic of inte-
grating family planning and HIV services. Moreover, the studies were mainly funded by the
private sector/ foundations.
Descriptive information about methodological characteristics and results is presented in
Table 2. The healthcare provider perspective was used on most included studies, either men-
tioned explicitly or not. From all nine studies, six used an economic model (decision tree or
Markov), two studies used demographic data and the other one used data from a cluster-ran-
domized trial to perform the evaluation. None of the studies concerning the cost effectiveness
of integrated HIV service and family planning used GDP per capita as a benchmark to con-
sider the cost-effectiveness of the interventions. Most other studies however, used GDP per
capita as a benchmark, to assess the willingness to pay threshold for their analysis. While most
of the studies considered a lifetime time horizon for the analysis, the studies in HIV-positive
women considered a relatively short (1 year) time horizon for their analysis. Despite the fact
that many studies applied a lifetime time horizon, only very few mentioned or reported the
discount rates for both cost and health outcome [26,29,30]. Detailed information about catego-
ries of included costs was provided in Table 3.
Fig 1. PRISMA flow diagram depicting the process of the study selection.
doi:10.1371/journal.pone.0168447.g001
Economic Evaluation of Family Planning
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Table 3. Perspective and category of included costs.
Study Perspective Cost year
and
currency
Discount rates Cost breakdown
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Improving family planning interventions in L-MICs. This review identified several eco-
nomic evaluation studies that assessed various strategies to reduce the unmet need for family
planning in L-MICs. The results were similar among included studies, suggesting that reduc-
ing unmet need for family planning would be highly cost effective, as strategies for spacing and
limiting births would have significant benefits for both mothers and infants and also reduce
the demand for elective abortion in the regions.
Studies in Mexico [25], India [26], Afghanistan [27] and Nigeria [28] revealed similar
results. Increasing the provision of family planning was cost effective and family planning cou-
pled with integrated services for maternal care (such as improved access to antenatal/ postpar-
tum care and emergency obstetrical care) would prevent four out of five maternal deaths and
have an ICER less than countries with an equal GDP/ capita per year live saved (YLS), a com-
mon benchmark for cost effectiveness. Compared to other strategies to reduce maternal mor-
bidity and mortality, reducing the unmet need for family planning is the most cost-effective
single intervention. These four studies used a similar decision analytic model to assess the
potential cost effectiveness of the various strategies and extrapolated the model to each coun-
try’s settings. While the model estimated the natural course of pregnancy using a lifetime time
horizon, most studies did not estimate both discounted cost and health outcomes. All studies
performed similar deterministic sensitivity analyses with rather diverse results. With regard to
family planning, it seemed that varying the cost of increasing coverage and also effectiveness of
the interventions had the highest impact on the outcomes [25–28].
In Uganda [29], reducing the unmet need and improving the universal access to modern
contraception appeared to be highly cost effective compared to the status quo where the access
was limited, as seen from both a societal and governmental perspective. The model compared
the new strategy with the current situation with regard to costs, life expectancy, ICER per life
year saved (LYS) and disability-adjusted life years (DALY) averted during a lifetime time hori-
zon. The analyses suggested that mean discounted life expectancy was slightly higher for the
new strategy with ICER/ DALY dominating the comparator, i.e. the new strategy would be less
costly at a more favorable health outcome. Univariate and probabilistic sensitivity analyses
were performed to assess which parameters had significant impact on results. The results
showed that cost of both contraception and pregnancy appeared to be the most sensitive vari-
ables for incremental cost and discount rate was the most sensitive parameter for incremental
DALYs. It was also uncertain whether the new strategy was less costly than the current
Table 3. (Continued)
Study Perspective Cost year
and
currency
Discount rates Cost breakdown















IUD = Intrauterine device
PMTCT = Prevention of mother-to-child transmission
aModern contraceptives including oral contraceptives, injectable contraceptives, barrier contraceptives, intrauterine device, female and male sterilization
weighted by the costs of healthcare personnel and services
b Including costs of healthcare personnel and other healthcare materials
doi:10.1371/journal.pone.0168447.t003
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strategy. The new strategy took into account not only the cost of the interventions but also any
costs on the consequences, as well as the associated costs or savings further down the line.
However, it was very likely that the new strategy was more effective, as quantified in probabi-
listic sensitivity analysis.
The projected health benefits associated with an increased investment to reduce the unmet
need for family planning were modeled by Kennedy, et al for Vanuatu and the Solomon
islands, small developing states in the Pacific Islands [30]. Demographic modeling was used in
the analysis to assess the economic consequences of the strategy. It was estimated that meeting
the needs of family planning would increase modern contraceptive use approximately by 20%
for both states and reduce the rate of unintended pregnancy and high-risk births as well as the
number of abortions significantly. This strategy would also slow down annual population
growth, and therefore lower the youth dependency ratio. The analysis took a service delivery
perspective, and included all direct costs associated with providing family planning. Increased
investment in family planning in these small states was estimated to result in considerable pub-
lic sector savings [30].
Improving family planning interventions for HIV-positive women in L-MICs. The
remaining three studies in the review assessed the impact of improved family planning interven-
tions in HIV-positive women, mainly to prevent unintended pregnancy among HIV-positive
women who do not wish to become or want to delay pregnancy and to avert HIV transmission
from mothers to their infants. The overall results from all studies suggested that integrated family
planning and HIV services were considered cost-effective and efficient. Sensitivity analysis to
assess the uncertainty that may be present in the results was not performed in most of these stud-
ies, making it difficult to evaluate reliability of the conclusions.
A study by Reynolds et al evaluated cost effectiveness of family planning to prevent unin-
tended pregnancy among HIV-positive women in sub-Saharan Africa [24]. Evaluation of peri-
natal HIV transmission prevention in a hypothetical sub-Saharan Africa cohort was modeled
to assess relative cost-effectiveness of universal access to family planning to reduce the unmet
need by approximately 90% for all sexually active women, compared with improved access to
HIV testing and counseling coupled with nevirapine prophylaxis (referred to nevirapine for
PMTCT in prenatal care) to avert HIV-positive births. The results suggested that reducing the
unmet need of family planning without consideration of HIV status is at least as cost-effective
as reducing HIV transmission by nevirapine for PMCTC. The study estimated that increasing
contraceptive use among all women who do not wish to become pregnant would avert approx-
imately 30% more HIV-positive births than the other strategy would prevent [24]. Sensitivity
analysis on different assumptions about the costs of either programs or effectiveness of nevira-
pine for PMTCT suggested that effectiveness of nevirapine seemed to be the most sensitive
parameter in the model.
Cost effectiveness of integrated family planning and HIV services was the main topic of two
studies by Halperin, et al [31] and Shade, et al [32]. Both studies suggested that the approach to
integrate family planning and HIV services was efficient as well as cost-effective to prevent
perinatal HIV transmission and unintended pregnancies [31,32]. Family planning becomes an
important aspect in HIV services, as women and couples with HIV may access family planning
not only to prevent unintended pregnancy but also to plan healthy pregnancy when desired
[33]. Halperin et al estimated that providing antiretroviral (ARV) prophylaxis would prevent
approximately two hundred thousand HIV infections to infants in countries with high-level
epidemics of HIV. However, an estimated seventy thousand infants would still be infected
with HIV, even with full access of ARV prophylaxis in prenatal care. These infections could
have been averted by preventing unintended pregnancy via family planning.
Economic Evaluation of Family Planning
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Meanwhile, analysis of a cluster-randomize trial in one province in Kenya [32] estimated
that integration of family planning in HIV services was feasible, efficient and also cost effective
in the Kenyan setting with the costs being within the range of the estimated value and higher
efficacy than the previous estimation taken from the study by Reynolds et al [24].
Quality of reporting
Based on reporting quality assessment from the CHEERS checklist, four studies were ranked
as good, four as moderate and the other one was categorized as low. Studies which focused on
expanding family planning interventions were rated as having good or moderate quality of
reporting; studies which focused on integrating family planning into HIV care were rated as
having moderate or low quality of reporting.
Table 4 shows the proportion of each item in the CHEERS checklist that is reported suffi-
ciently, partially, or not at all by all included studies in the review. Most studies failed to fully
report details on how resources and costs were collected and estimated, along with poor
reporting of the discount rate. Additionally, four out of nine studies also did not report study
perspective when describing included costs. Most studies reported the incremental cost effec-
tiveness ratio of the family planning interventions compared to alternative strategies or current
situation. Discussions related to key findings, limitations and generalizability mostly provided
although several studies did not comprehensively assess these criteria. Only half of studies
reported source of funding and potential conflicts of interest. Furthermore, no studies stated
the role of funder in the identification, design, conduct and reporting of the analysis.
Discussion
We conducted a systematic review of economic evaluation studies assessing strategies to
improve family planning interventions by reducing the unmet need in resource-limited set-
tings. Generally, the included studies suggested that the interventions to increase the preva-
lence of family planning in a variety of L-MIC settings can be cost-effective or cost saving as
measured against accepted thresholds for estimating cost effectiveness [34]. There was diver-
sity in the strategies, the measures of effectiveness and outcomes, the scales of implementation
and also the study setting. In addition, the number of studies in this area is still limited, which
limits our ability to draw strong conclusions.
This review also highlighted the lack of economic evaluation studies that assessed explicit
interventions to improve both supply and demand for contraceptives in L-MICs. During the
1970s-1980s, family planning programs were on the rise with increased funding from interna-
tional support, and it was considered an essential period since important developments such
as increased use of contraceptives and reduced fertility were observed all over the world
[10,35], A more comprehensive rationale for family planning programs was also introduced
after this period, with the purpose of women’s empowerment and reproductive health and
rights [10]. However, family planning has shifted away from international development priori-
ties that led to limited funding in the period from the 1990s [10,35], up until recently when
increased attention and renewed focus on family planning were being re-introduced [1,36,37].
Over the last years, broadening the discussion regarding the impact of family planning on the
socio-economic development and demographic dividend, in addition to health and rights of
women and girls, has contributed to this renewed and enhanced focus [10]. With high unmet
need and relatively low modern contraceptives coverage in LMICs, information on costs and
cost-effectiveness of investments in strategies to reduce the unmet need seems needed for pol-
icymakers in order to effectively allocate limited resources.
Economic Evaluation of Family Planning
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The conclusion from the studies which assessed family planning as a possible strategy to
reduce maternal morbidity and mortality, suggested that these early intensive efforts to scale up
family planning interventions contributed significantly to the decreasing number of maternal
deaths [25–28]. Compared to other interventions that were assessed in addition to increased
family planning i.e safe abortion, increased skilled attendants, improved antenatal/postpartum
care, incrementally shifted births away from home, and improved availability and quality of
emergency obstetrical care (EmOC), family planning was the most cost-effective individual
intervention to reduce maternal mortality. The implementation of this early intervention
seemed to play an important role since strategies to improve contraceptive options as a way to
assist fertility choices for women do not require complex integrated infrastructure as opposed
to the other strategies [25–28].
Women living with HIV are a population with a considerable unmet need for family plan-
ning [38,39], thus averting unintended pregnancy among this population is a cost-effective
way to improve maternal and child health [40]. Concerns in the global health community had
shifted during the past ten years from reproductive health to HIV [39]. However, recently it
has been suggested that integrating HIV with reproductive health has potential to improve the
quality, continuity and efficiency of care for those living with HIV [41]. There were three stud-
ies in this review that analyzed the cost effectiveness of family planning for HIV-positive
women, all of them performed in African countries. The vast majority of people living with
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region [42]. The conclusions from most of the included studies were in line with current
WHO recommendations on integration of HIV services. However, support for integration of
family planning into HIV care is only supported by a very limited number of studies with low
to moderate quality of reporting. Therefore, additional studies are needed to better describe
the potential economic benefits of integrated HIV care and family planning services.
Favorable health consequences with regard to family planning can contribute to achieve
some points in MDG 5, mainly by reducing the number of unintended pregnancies as well as
maternal and infant morbidity and mortality [17]. Investment in women’s and children’s
health would also substantially secure health, economic and social returns. It was suggested
that scaling up access to contraceptives would be a predominantly cost-effective investment
that contributes to the prevention of maternal death [17].
Studies that reported the outcomes in a measure of cost per year life saved (YLS) or cost per
disability adjusted life year (DALY) averted concluded that the strategies involving increased
access of family planning in some of developing countries were cost-effective when compared
to their GDP per capita [25–29]. DALY is a widely accepted health impact metric for cross-
country comparisons and the outcomes of the cost per DALY averted is widely accepted as a
benchmark to assess the cost utility of healthcare interventions and has been widely used to
directly compare relative cost-effectiveness in different national settings [43]. However, using
GDP per capita as a threshold to estimate the cost-effectiveness of interventions might only be
valid from a national perspective and is therefore not applicable outside the study’s setting
[44,45]. Also, using national thresholds when making international comparisons is somewhat
risky, mainly because it does not distinguish cost-effectiveness and affordability [44]. The alter-
native approaches for estimating thresholds for cost effectiveness are using benchmarks inter-
ventions or league tables, if possible [45]. The threshold for benchmark interventions is
established by retrospective analysis of relevant current practice, while league tables is to basi-
cally rank all relevant options according to their ICERs. The purpose for these methods is to
facilitate decision makers with more thorough assessment on relevant alternatives to efficiently
utilize national welfare [45].
In global health issues, where the funding could also come from non-governmental organi-
zations, the cost-effectiveness analysis from a transnational perspective with equal value gains
would allow for a cross country comparison and enforce resource allocation that would maxi-
mize health gains [44].
A lack of empirical data on both costs and effectiveness, especially for approaches to
increase supply and demand for modern contraceptives, was observed among included stud-
ies, which indicates a need for trials in this particular area. Despite the many advantages a
modeling framework offers, such as the synthesis of evidence from multiple sources, enhanced
with relevant assumptions to extrapolate the outcomes over a longer time horizon [46], empir-
ical data remains essential as a steady basis for these decision analytic models and to reduce
uncertainty in the model outcomes.
The CHEERS checklist provides standards for the kind of information that should be
reported in economic evaluation studies. Even though there were studies that have adequately
fulfilled the standards in the checklist, many studies did not comply with the guidelines. In
some studies, inadequacy in reporting made it difficult to actually assess whether the method-
ology used in the analysis, such as the approach to estimate resources and costs, the costing
perspective, the time horizon, discount rates and analytical methods was appropriate. Some
studies provided sufficient information in the appendices, which can be an alternative, as
many peer-reviewed journals have restrictions on the length of an article.
To the best of our knowledge, this study is one of the first reviews assessing the health eco-
nomics of strategies to improve family planning interventions in L-MICs [47]. Previous studies
Economic Evaluation of Family Planning
PLOS ONE | DOI:10.1371/journal.pone.0168447 December 19, 2016 15 / 19
that evaluated cost effectiveness of strategies to improve maternal and infant health suggested
that improving the utilization and provision of maternal and infant healthcare is cost effective
in low income and lower-middle income countries [15]. However, provision of family plan-
ning as the early intervention in RMNCH had not been assessed exclusively until now. Part of
the result from this review also elaborated on previous review, which assessed the costs and
efficiency of integrating HIV/AIDS services with other health services [41]. It was concluded
that a range of integrated HIV services were found to be cost effective, however the evidence to
integrate HIV services with family planning services remain limited [41].
The results of this review are of importance to decision makers, as the results of cost-effec-
tiveness analyses should be compared with many other relevant interventions in a specific con-
text. Therefore decision makers would be in a better position to interpret and prioritize among
the many competing global health needs.
Inevitably, this review has several limitations. We took a systematic approach in the litera-
ture search and screening process; however there is a chance that there were relevant studies
that have been missed. In addition, due to variability of interventions and strategies that were
assessed in the included studies, comparability of studies is limited. However in this review, we
facilitate this with a narrative approach, therefore the variation in methodology and study
designs can be observed thoroughly. Also, as all the included studies in this review had positive
findings, therefore publication bias is also a potential limitation. This could mean that cost
effectiveness analyses with negative findings might not have been published. Individual inter-
pretation while assessing the quality of reporting could also lead to bias as the checklist some-
times contained several recommendations per point.
Conclusion
This review provides a comprehensive health economic assessment of the available published
studies of improving family planning interventions in L-MICs. Due to increased attention for
economic evaluation of healthcare interventions in these countries, the results of this review
can be essential for any decision maker at different levels to assess the cost-effectiveness of
improving global health interventions, especially family planning.
In conclusion, improving family planning interventions to decrease the unmet need in low
and middle income countries appears to be cost-effective, however it depends on each coun-
try’s thresholds for considering cost effectiveness. Additional economic evaluation studies
with improved reporting quality are necessary to generate further evidence on costs, cost-effec-
tiveness, and affordability, and to support increased funding and investments in family plan-
ning programs.
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